What does Rallybio Corp (RLYB) do?

Rallybio Corp (RLYB) is a publicly traded company in the Healthcare sector.

What sector does RLYB operate in?

Rallybio Corp operates in the Healthcare, specifically within the Pharmaceutical Preparations industry. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find RLYB earnings analysis?

AlphaOS publishes an earnings intelligence page for Rallybio Corp (RLYB) covering results, guidance context, and AI-assisted analysis. See /stocks/RLYB/earnings. Content is for research and education — not investment advice.

Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

RLYB

Rallybio Corp

Healthcare · Pharmaceutical Preparations

$17.22Sep 29, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

Rallybio Corp shows decelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue -100% YoY in Q2 FY2026.

TrajectoryDecelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

Revenue -100% YoY in Q2 FY2026

Pipeline evidence · 0d ago

RLYB's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on RLYB.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full RLYB earnings analysis

Reported figures for Rallybio Corp — research only, not investment advice.

Revenue YoY: -100.0%

Latest Intelligence

Updated September 30, 2026

What happened recently for Rallybio Corp (RLYB) — events, not interpretation.

Event: Reported Q2 2026 revenue -100% YoY.
Also: Last session September 29, 2026 at $17.22.
Source: Q2 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

Rallybio Corp (RLYB)

Healthcare · Pharmaceutical Preparations

Investment Snapshot above is the primary AlphaOS analysis for Rallybio Corp — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:: Healthcare
Industry:: Pharmaceutical Preparations
Market cap:: $91.45M
Revenue:: $212,000

RLYB earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Rallybio Corp through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.